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Introduction
Copper metabolism MURR1 domain containing (COM MD) 
proteins are a group of highly conserved factors defined by the 
presence of a unique C-terminal homology domain (Burstein 
et al., 2005). Ten family members can be identified from mam-
mals to unicellular protozoa (Maine and Burstein, 2007), but 
little is known about their cellular functions and the underly-
ing reason for their conservation and diversification. Most of 
our understanding is centered on COM MD1, the first identified 
member of this family that was initially noted to be the site of a 
recessive mutation that results in copper toxicosis in a particular 
dog breed, the Bedlington terrier (van de Sluis et al., 2002).
The mechanism for the accumulation of copper in these 
animals was initially unclear; however, an interaction between 
COM MD1 and the copper transporter ATP7B was reported 
early on (Tao et al., 2003). Recently, we demonstrated that 
COM MD1 regulates the endosomal sorting of the copper trans-
porter ATP7A, such that in the absence of COM MD1, ATP7A 
is trapped in endosomal vesicles and lacks copper-dependent 
trafficking to the trans-Golgi network and plasma membrane 
(Phillips-Krawczak et al., 2015). In addition to its control of 
ATP7A/7B trafficking, COM MD1 has been linked to the reg-
ulation of other transporters, including epithelial sodium chan-
nel, cystic fibrosis transmembrane conductance regulator, and 
sodium-potassium-chloride cotransporter 1 (Biasio et al., 2004; 
Drévillon et al., 2011; Smith et al., 2013). However, whether 
these other transporters are similarly regulated at the level 
of endosomal sorting remains to be examined. Furthermore, 
COM MD1 has also been linked to other pathways that are seem-
ingly not connected to the endolysosomal system, including nu-
clear factor κB regulation (Maine et al., 2007; Starokadomskyy 
et al., 2013) and hypoxia adaptation (van de Sluis et al., 2010).
The role of COM MD1 in endosomal sorting is linked to 
its incorporation into a larger complex containing the coiled-
coil proteins CCDC22 and CCDC93 (Phillips-Krawczak et al., 
2015). This COM MD–CCDC22–CCDC93 (CCC) complex 
localizes to endosomes through interactions between CCDC22 
and CCDC93 with FAM21 (Harbour et al., 2012; Freeman et 
al., 2014; Phillips-Krawczak et al., 2015), a component of the 
Wiskott-Aldrich syndrome protein and scar homolog (WASH) 
complex (Derivery et al., 2009; Gomez and Billadeau, 2009). 
WASH is a member of the Wiskott-Aldrich syndrome protein 
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family of actin nucleation-promoting factors (Rottner et al., 
2010). Through its ability to recruit and activate the ubiqui-
tously expressed Arp2/3 complex, WASH promotes endosomal 
actin deposition and is required for the maintenance of the ar-
chitecture of the endolysomal system and to facilitate receptor 
trafficking (Derivery et al., 2009, 2012; Gomez and Billadeau, 
2009; Jia et al., 2010; Gomez et al., 2012).
COM MD proteins are known to interact with each other 
through their COMM domains (Burstein et al., 2005); more-
over, all COM MD family members have been shown to interact 
with the CCC complex component CCDC22 (Starokadomskyy 
et al., 2013). However, whether other COM MD proteins form 
distinct CCC entities and can mediate unique functions that dis-
tinguish them from COM MD1 has not been elucidated. At the 
present time, studies addressing functions of other COM MD 
proteins are scant and include roles in epithelial sodium channel 
regulation (Liu et al., 2013), regulation of cell proliferation and 
repair in kidney injury models (Devlin et al., 2003), effects on 
hepatocellular carcinoma (Zheng et al., 2012), and regulation of 
IκB protein degradation (Starokadomskyy et al., 2013).
In this study, we performed an extensive functional analy-
sis of COM MD9, a COM MD family member that is frequently 
deleted in WAGR syndrome (MIM 194072), a congenital condi-
tion caused by a microdeletion and haploinsufficiency at 11p13 
(Xu et al., 2008). We report that COM MD9 is incorporated into 
the CCC complex and plays a critical role in endosomal sorting 
of Notch family members. Upon ligand binding, Notch proteins 
undergo proteolytic cleavage to release the Notch intracellular 
domain, which in turn translocates to the nucleus and along with 
cofactors binds gene-promoter regions of chromatin to regulate 
gene expression (Kopan, 2012). Furthermore, extensive work in 
Drosophila and other models has uncovered that trafficking of 
Notch proteins through the endolysosomal system is critically 
important in regulating their activity (Wilkin et al., 2008; Fortini 
and Bilder, 2009; Kandachar and Roegiers, 2012; Troost et al., 
2012). Here we describe that in the absence of COM MD9, Notch 
expression is reduced at the cell surface and Notch2 is missorted 
into cytosolic vesicles from where it can reach lysosomes, re-
sulting in reduced Notch-dependent signaling. Furthermore, we 
show that Commd9 is critically required during mammalian de-
velopment and that it functions as part of a unique CCC complex.
Results
Identification of the COM MD9 interactome
To begin to understand what unique function COM MD9 might 
mediate, we used tandem affinity purification to define its pro-
tein interactome. To that end, COM MD9 was doubly tagged 
with a tandem HA tag in its N terminus and a short biotinylation 
sequence in its C terminus. The protein was immunopurified 
with an HA antibody first, and on elution, it was purified again 
using streptavidin resin. The final material, when resolved by 
SDS-PAGE and stained with silver nitrate, demonstrated sev-
eral unique bands in addition to the purified bait (Fig.  1  A). 
These bands were excised and subjected to trypsin digestion 
for proteomic identification by liquid chromatography tandem 
mass spectrometry (LC/MS-MS). This analysis identified 37 
interacting proteins with high confidence (Table S1). CCDC22, 
CCDC93, and COM MD5, components of a recently identified 
regulator of endosomal protein sorting (Starokadomskyy et al., 
2013; Phillips-Krawczak et al., 2015), were found in this pu-
rification (Fig. 1 B). The Rab proteins RAB5C, RAB7A, and 
RAB11B, which are present in different endosomal subcom-
partments, were also found. In addition, several transmembrane 
surface proteins were also identified (Fig. 1 B). Among these 
proteins, Notch2 was identified through four peptides mapping 
to both the N-terminal extracellular portion of the receptor and 
its C-terminal tail. This receptor was of interest to us because 
of its important developmental roles (High and Epstein, 2008).
COM MD9 interacts with Notch proteins
The interaction between COM MD9 and Notch2 was readily re-
capitulated by coimmunoprecipitation, which also detected that 
COM MD9 interacts with members of the CCC complex, as ex-
pected (Fig. 1 C). Furthermore, COM MD9 also coimmunoprecip-
itated Notch1, another family member (Fig. 1 D); in comparison, 
Notch3 was not coprecipitated to a significant degree (Fig. 1 E).
COM MD9 and the CCC and 
retromer complexes regulate surface 
levels of Notch2
The CCC complex is a regulator of endosomal sorting 
events mediated by retromer and WASH, including the endo-
some-to-surface recycling of the copper transporter ATP7A 
(Phillips-Krawczak et al., 2015). With this in mind, we rea-
soned that COM MD9 might similarly regulate the recycling of 
Notch2 to the plasma membrane. To assess this possibility, we 
screened a series of Notch2 antibodies and cell lines to iden-
tify suitable reagents that allow immunofluorescence staining 
of the endogenous protein. Among different laboratory variants 
of HeLa cells, we identified a subline with high expression of 
Notch2 that is suitable for immunofluorescence staining. Next, 
we derived COM MD9 knockout clones of this cell line using 
CRI SPR/Cas9 gene editing technology using two separate guide 
RNA sequences targeting exon 1 of COM MD9 (Fig. S1 A). All 
three clones had no detectable protein expression (Fig.  2  A), 
and genomic analysis demonstrated short deletions in the tar-
geted region (Fig. S1, B and C). In these cells, we identified 
that the normal surface staining pattern of Notch2 was largely 
lost, and instead, this was replaced by prominent intracellular 
vesicular staining for Notch2 in all three clones (Fig. 2 B). Fur-
thermore, although the overall Notch2 protein expression was 
only modestly decreased in these cells, surface protein bioti-
nylation demonstrated a substantial reduction of Notch2 in this 
fraction (Fig. 2, C and D), consistent with the reduced plasma 
membrane staining pattern noted by immunofluorescence stain-
ing. In addition, we also examined the nature of the intracellu-
lar Notch2 accumulation seen in COM MD9-deficient cells. The 
intracellular Notch2 puncta in COM MD9-deficient cells partly 
colocalized with EEA1, and to a lesser extent with VPS35 (Fig. 
S2, A and B). Consistent with the notion that these puncta 
represent early endosomes, Rab5 colocalized with Notch2 in 
COM MD9-deficient cells, whereas the colocalization with the 
recycling endosome marker Rab11 was poor (Fig. S2 C).
Next, expression of COM MD9 was restored in two of the 
targeted clones to ensure that these observations were indeed 
specific to COM MD9 targeting (Fig. 2 E). Surface biotinylation 
experiments demonstrated that the rescued lines had increased 
Notch2 levels at the cell surface (Fig. 2, F and G), indicating that 
this cellular phenotype is rescued by COM MD9 re-expression. 
Furthermore, silencing of CCDC93 or C16orf62 (two addi-
tional components of the CCC complex) also led to reduced 
plasma membrane staining for Notch2, a pattern also observed 
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on silencing of VPS35 (Fig. S3, A and B), a subunit of the ret-
romer complex which is important for WASH recruitment and 
function (Harbour et al., 2012; Jia et al., 2012). Altogether, 
these findings indicate that the absence of COM MD9 and as-
sociated factors results in the accumulation of Notch2 in the 
early endosomal compartment.
COM MD9 is required for optimal 
Notch signaling
Next we assessed the effects of COM MD9 on Notch-dependent 
gene expression. COM MD9-deficient HeLa cell clones dis-
played decreased basal expression of several Notch-dependent 
genes, but this HeLa subline proved to be poorly responsive to 
Figure 1. Identification of COM MD9-interact-
ing proteins. (A) Tandem affinity purification 
of COM MD9 (HA and TB tagged) in HEK293 
cells was followed by SDS-PAGE and silver 
staining. The location of the bait, or the control 
polypeptide expressed by the empty vector, is 
marked by an asterisk. Other coprecipitated 
bands are evident in the COM MD9 lane. 
Molecular mass markers (in kD) are noted. 
(B) Top hits identified by LC/MS-MS. (C) 
Confirmation of the endogenous interaction 
between COM MD9 and Notch2. COM MD9 
was immunoprecipitated with specific anti-
bodies, and the precipitates were immuno-
blotted for Notch2 (using an antibody that is 
specific for its C-terminal region) and other 
proteins as indicated. Molecular mass mark-
ers (in kD) are noted. (D and E) COM MD9 
interacts with Notch1 but not Notch3. Endoge-
nous COM MD9 was immunoprecipitated and 
associated proteins were immunoblotted for 
Notch1 (D, two individual antibodies that are 
specific for Notch1 C terminus) and Notch3 
(E). Molecular mass markers (in kD) are noted.
Figure 2. COM MD9 regulates the surface local-
ization of Notch2. (A) Generation of COM MD9- 
deleted HeLa cells with CRI SPR/Cas9 tech-
nology (Cr-COM MD9). Western blots for 
COM MD9 are shown in three clones derived 
using two different guide RNA sequences 
(gRNA). Molecular mass markers (kD) are noted. 
(B) Localization of Notch2 in parental HeLa 
cells and in Cr-COM MD9 clones was assessed 
by immunofluorescence staining. Bars: (top) 20 
μm; (bottom) 5 µm. (C and D) Surface Notch2 
was also assessed by biotinylation, precipi-
tation, and immunoblotting as described in 
the Materials and methods section (C). The 
immunoblots for N-cadherin serve as loading 
controls. Molecular mass markers (in kD) are 
noted. Semiquantitation was performed by 
densitometry analysis, and the averages of 
three independent iterations are presented (D). 
Error bars represent the SEM. *, P < 0.05. (E) 
HA-COM MD9 was reintroduced using a lenti-
viral vector resulting in rescued expression of 
COM MD9 in clones 1 and 3, as shown here 
by immunoblotting. Molecular mass markers 
(in kD) are noted. (F and G) Notch2 surface 
expression was assessed by biotinylation and 
immunoblotting (E). Molecular mass markers 
(in kD) are noted. Semiquantitation by den-
sitometry analysis and the averages of three 
independent iterations are presented (G). Error 
bars represent the SEM. *, P < 0.05.
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stimulation with exogenous Jagged1 ligand (unpublished data). 
Therefore, we used alternative models to investigate this ques-
tion. First, U2OS cells with stable silencing or stable overex-
pression of COM MD9 were used (Fig. 3 A). Using Jagged1 as 
ligand for Notch stimulation, we noted that COM MD9 silencing 
led to reduced induction of HEY1, a Notch target gene, whereas 
overexpression of COM MD9 had the opposite effect (Fig. 3 B). 
Furthermore, these cells were transfected with a Notch-respon-
sive luciferase reporter containing a promoter with multimerized 
RBPj binding elements. Here we observed that the effects of 
COM MD9 expression on the Notch reporter were concordant 
with the observed effects on HEY1 expression (Fig. 3 C), con-
sistent with the notion that endogenous HEY1 gene expression 
was indeed affected through a Notch-dependent event.
For further analysis, we used mouse embryo fibroblasts 
(MEFs) derived from a gene trap Commd9-deficient model, 
where a gene trap cassette was inserted between exons 5 and 6 
of the mouse Commd9 gene (Fig. S4 A). This targeted allele 
is in effect a complete knockout because Commd9 protein ex-
pression in mutant MEFs is undetectable (Fig. S4 B). Commd9- 
deficient MEFs from this gene trap model demonstrated sub-
stantial reductions in Jagged1-mediated induction of Notch 
target genes, such as Hey1, Hey2, and Hes1, whereas TGF-β1 re-
sponses were unaffected (Fig.  3  D). Furthermore, re-expression 
of Commd9 in these MEFs (Fig. S4 C) restored Hey1 expression 
in this cell model (Fig. 3 E). Finally, we tested a second gene inac-
tivation model that relies on the introduction of LoxP sites flanking 
exon 3 of the mouse Commd9 gene (Fig. S4 D). MEF lines were 
derived from two embryos, and isogenic pairs lacking Commd9 
expression were generated in culture by transient expression of 
Cre recombinase (Fig. S4 E). In agreement with previous observa-
tions, Commd9 deficiency was associated with blunted activation 
of Notch target genes. This was true in response to plate-bound 
recombinant Jagged1, or when OP9 cells that stably express Jag-
ged1 were used as a source of ligand (Fig. 3 F). Altogether, these 
findings indicate that COM MD9 is required for optimal activation 
of Notch-dependent gene expression, in agreement with the role of 
this protein in maintaining surface expression of Notch2.
COM MD9 prevents the lysosomal 
degradation of Notch
Inactivation of retromer is frequently associated with missort-
ing of endosomal protein cargoes to lysosomes, resulting in 
protein degradation (Steinberg et al., 2013). We noted a modest 
reduction of Notch2 in HeLa cells (Fig. 2 C) and assessed this 
phenomenon in other cell models. In this regard, we found that 
COM MD9 silencing in HEK 293 cells led to more notable re-
duction in Notch2 protein expression (Fig. 4 A). Unlike Notch2, 
silencing of COM MD9 had little impact on Jagged1 expression 
(Fig. 4 B). A similar phenomenon was noted for Notch1 and 
Notch2 in Commd9-deficient fibroblasts (Fig. 4 C), and this re-
duction was also noted in the cell surface fraction (Fig. 4 D). 
Importantly, Bafilomycin A1, an inhibitor of lysosomal acid-
ification and protease activity, restored Notch2 expression in 
MEFs (Fig. 4 E). Altogether, these data are consistent with the 
notion that COM MD9 deficiency results in missorting of Notch 
Figure 3. COM MD9 deficiency impairs 
Notch-dependent gene expression. (A) U2OS 
cells stably deficient in COM MD9 or express-
ing HA-COM MD9 were generated using len-
tiviral vectors. COM MD9 Western blots with 
molecular mass markers (in kD) are shown. (B) 
U2OS cells shown in Fig. 3 A were stimulated 
with Jagged1 (plate bound), and the induction 
of HEY1 mRNA was determined by qRT-PCR. 
Triplicate samples were averaged, and error 
bars represent the SEM. *, P < 0.05. (C) The 
same cells shown in Fig. 3 A were transfected 
with a Notch-responsive luciferase reporter. Lu-
ciferase activity was determined and normal-
ized against the control conditions. Triplicate 
samples were averaged. Error bars represent 
the SEM. *, P < 0.05. (D) Immortalized MEFs 
obtained from wild-type (WT) or COM MD9- 
deficient (KO) littermate embryos were used. 
Cells were stimulated with Jagged1 (plate 
bound) or TGF-β (soluble), and the induction 
of Notch-responsive genes (Hey1, Hey2, and 
Hes1) or TGF-β responsive genes (Junb) was 
assessed by qRT-PCR. Triplicate samples were 
averaged. Error bars represent the SEM. *, P < 
0.05. (E) Furthermore, COM MD9 expres-
sion was rescued in the KO line using a len-
tivirus, and the responsiveness of this control 
line was examined and compared against 
an empty vector control. Triplicate samples 
were averaged. Error bars represent the SEM. 
*, P < 0.05. (F) MEFs derived from an embryo 
with a conditional Commd9 allele (F/F) were 
used to derive Commd9-deficient cells (−/−). 
These cells were stimulated with plate-bound 
Jagged1 (left) or cell-bound Jagged1 (right) 
and the induction of Notch responsive genes 
(Hey1, Hey2, and Hes1) was monitored by 
qRT-PCR. Triplicate samples were averaged. 
Error bars represent the SEM. *, P < 0.05.
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proteins through the endolysosomal system, leading to their 
lysosomal degradation.
Commd9 deficiency leads to abnormalities 
in cardiovascular development
In view of the aforementioned findings, and the important roles 
of Notch during embryogenesis (High and Epstein, 2008), we 
suspected that Commd9 deficiency in mice could impair sev-
eral developmental processes, including in the cardiovascu-
lar system. First, we observed that gene trap targeting of the 
Commd9 locus was not viable at birth, and timed pregnancies 
indicated that the expected Mendelian rate was last observed at 
embryonic day (E) 10.5 (Fig. 5 A). At this stage, Commd9-de-
ficient embryos displayed neural edema (Fig. 5 B), which was 
followed a day later by hemorrhages, starting in the head of the 
embryo and soon after observed throughout the body (Fig. 5 B, 
and C). Several other morphologic changes were noted, most 
notably in the cardiovascular system. Hypoplasia of the heart 
was a universal finding at E10.5 and beyond (Fig. 5 D), with 
foci of focal wall necrosis and pericardial bleeding noted by 
E11.5 (Fig. S4 F). Furthermore, mutant embryos displayed sev-
eral vascular changes, including focal narrowing of the dorsal 
aortas (Fig. 5 E). Whole-mount immunohistochemistry staining 
for the endothelial marker Pecam1 revealed additional alter-
ations in cranial blood vessels, particularly a dramatic reduc-
tion in truncal vessels connected to the distal capillary networks 
(Fig. S4 G). Further analysis with markers of arterial (Cx40) 
and venous (Apj) vessels revealed normal arterial structures but 
substantial changes in venous vasculature formation, with ec-
tatic dilations noted in the embryo’s head (Fig. S4 H). To assess 
if these changes were at least in part related to altered Notch 
signaling, we isolated heart mRNA from somite-matched em-
bryos at E10.5. Indeed, a reduction in Hey1 and Hey2 mRNA 
expression in the heart was noted (Fig. 5 F), in line with the 
findings made in MEFs derived from this mouse strain (Fig. 3).
Interestingly, germline targeting in the Commd9 floxed 
mouse recapitulated the embryonic lethality noted in the gene 
trap model (Fig. S4 I). However, endothelial (Tie2-Cre), myo-
cardial (Nkx2.5-Cre), and smooth muscle (Sm22-Cre) targeting 
were all viable and did not recapitulate the embryonic lethal phe-
notype observed with whole-body deficiency (Fig. S4 I). There-
fore, we concluded that the embryonic lethality we observed 
resulted from alterations in more than one discrete cell lineage.
COM MD9 forms preferential complexes 
with COM MD5 and COM MD10
Commd1 deficiency in mice has been shown to result in em-
bryonic lethality (van de Sluis et al., 2007), with a pheno-
type that is earlier to that observed in the Commd9-mutant 
embryos studied here. Therefore, despite the similarities be-
tween these proteins, they serve nonredundant developmen-
tal functions that cannot be compensated by other COM MD 
proteins. To try to understand the potential basis for the 
specific effects noted for COM MD9 deficiency, we exam-
ined whether COM MD9 exists in a complex that is distin-
guishable from COM MD1. A side-by-side comparison of 
endogenous COM MD proteins associating with COM MD9 
and COM MD1 indicated that both proteins coimmunopre-
cipitated with each other and result in similar recovery of 
several COM MD proteins, such as COM MD2, COM MD4, 
COM MD6, and COM MD8 (Fig. S5 A). However, COM MD5 
and COM MD10 bound preferentially to COM MD9 over 
COM MD1. This suggested that COM MD9 and COM MD1 
might coexist in overlapping but not identical complexes, and in 
Figure 4. COM MD9 deficiency leads to lyso-
somal degradation of Notch. (A) HEK293 cells 
were transfected with a Notch2 expression 
vector; siRNA was used to concurrently silence 
COM MD9 expression. Notch2 expression 
was monitored using antibodies that recog-
nize the extracellular domain (Notch2-N) or 
an intracellular epitope (Notch2-C). Molecular 
mass markers (in kD) are shown. (B) HEK293 
cells were transfected with a Jagged1 expres-
sion vector; siRNA was used to concurrently 
silence COM MD9 expression. Jagged1 ex-
pression was evaluated using Jagged1 or 
FLAG antibodies. Molecular mass markers 
(in kD) are shown. (C) Levels of Notch1 and 
Notch2 expression in two Commd9-deleted 
cell lines (−/−) and their isogenic controls 
(F/F) were determined by immunoblotting. 
Molecular mass markers (in kD) are shown. 
(D) Using Commd9 F/F and −/− MEFs, total 
Notch1 and Notch2 levels (whole-cell lysates 
[WCLs]) were determined in by immunoblot-
ting (left). In addition, surface levels of both 
proteins (plasma membrane [PM]) were also 
determined by biotinylation and immunoblot-
ting (right). Molecular mass markers (in kD) are 
shown. (E) The reduced expression of Notch2 
shown in Fig. 4 C is rescued by Bafilomycin A1 
(BafA) treatment, an inhibitor of endolysosomal 
acidification that impairs lysosomal proteases. 
Molecular mass markers (in kD) are shown.
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agreement with this, different ratios of COM MD9 
and COM MD1 recovery were noted in each immuno-
precipitation (Fig. S5 A).
In an additional analysis, five COM MD proteins were im-
munoprecipitated, demonstrating once again that COM MD9 
was best immunoprecipitated by COM MD5 and COM MD10 
(Fig. S5 B). Furthermore, COM MD5 was also more abun-
dant in COM MD9 and COM MD10 immunoprecipitations, 
and the equivalent observation was made regarding COM 
MD10 (Fig. S5 B). In contrast, COM MD4 and COM MD6 
only coimmunoprecipitated minimal amounts of COM MD5, 
COM MD9, and COM MD10. Corresponding to these inter-
actions, COM MD9 and COM MD5 were found to colocalize 
in cytosolic puncta (Fig. 6 A). Altogether, these observations 
suggested that COM MD5, COM MD9, and COM MD10 form 
preferential complexes.
Finally, we examined whether key COM MD complexes 
observed here form through direct protein-protein interactions 
or are mediated indirectly through other factors present in 
cells. To that end, COM MD proteins were expressed recombi-
nantly in Escherichia coli, and their ability to form complexes 
was assessed by coprecipitation. This analysis indicated that 
COM MD9 can bind directly to COM MD5, in agreement with 
the coimmunoprecipitation from cell lysates (Fig. 6 B). Inter-
estingly, in this in vitro system, COM MD1 was able to bind to 
both COM MD5 and COM MD6, suggesting that additional cel-
lular mechanisms might regulate the preferential in vivo bind-
ing of COM MD5 to COM MD9.
COM MD9 and COM MD5 are preferentially 
involved in Notch regulation
Further examination indicated that loss of COM MD9 ex-
pression did not affect COM MD5 or COM MD10 expres-
sion in HeLa cells (Fig. 7 A) but abrogated their interactions 
with the CCC complex subunit CCDC22 (Fig.  7  B). In con-
trast, binding of CCDC22 with COM MD4, COM MD6, and 
COM MD8 was unaffected in these cells. Therefore, COM MD5 
and COM MD10 are incorporated into the CCC complex in a 
COM MD9-dependent manner.
Next we examined the possibility that COM MD9-contain-
ing complexes are specifically involved in Notch2 regulation. To 
examine this, all 10 COM MD genes were individually silenced, 
and their effects on Notch2 expression were examined by im-
munoblotting. Only COM MD9 and COM MD5 silencing led to 
reduced Notch2 levels (Fig. 7 C). In agreement with this result, 
recombinant COM MD5-containing complexes were able to bind 
in vitro with an immunopurified C-terminal Notch2 polypeptide 
(Fig. 7 D). In contrast, COM MD1–COM MD6 complexes were 
unable to bind to Notch2. Collectively, these data suggest that 
COM MD9 forms unique COM MD heterocomplexes in cells that 
are required for the trafficking of Notch receptors.
Discussion
This study sheds light into a previously unappreciated role 
for COM MD9 in vesicular sorting and the delivery of Notch 
Figure 5. COM MD9 deficiency leads to embryonic 
lethality and complex cardiovascular abnormalities. 
(A) Genotyping results at different developmental 
stages demonstrate that Commd9-deficient mice (gene 
trap knockout [KO] model) are not viable at birth. Ex-
pected Mendelian rates are seen at E10.5.  (B) KO 
embryos display neural tube edema (white arrows), 
seen by E10.5 (left). This is followed by punctate 
hemorrhages (yellow arrows), seen at E11.5 (right). 
WT, wild type. Bar, 500 µm. (C) KO embryos even-
tually developed widespread hemorrhages that are 
apparent by E11.5 and at later stages. Bar, 500 µm. 
(D) Cross-sectional histologic analysis demonstrated 
small hypoplastic hearts in all KO embryos. Bar, 
200 µm. (E) Areas of unilateral narrowing of the 
dorsal aorta were commonly seen in mutant embryos 
(arrow). Bar, 100 µm. (F) Hearts were isolated from 
somite-matched E10.5 embryos. RNA was extracted 
from these organs, and qRT-PCR was used to deter-
mine the relative level of expression of two Notch tar-
get genes (Hey1 and Hey2) and Commd9.
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proteins to the cell surface. Absent COM MD9, Notch is mis-
localized in intracellular early endosomes, and the response 
to Notch ligands is substantially attenuated. Furthermore, our 
studies indicate that Notch is not only mislocalized but also 
undergoes lysosomal degradation. Interestingly, we found 
that similar phenotypes are observed in cells deficient in CCC 
components CCDC93 and C16orf62 and the retromer subunit 
VPS35. This latter complex, which is critically important for 
the endosomal recycling of a large number of receptors (Sea-
man et al., 2013), has not been previously linked to Notch traf-
ficking (Steinberg et al., 2013).
The observation that COM MD9-dependent effects on 
Notch trafficking can dramatically affect signaling is in line 
with a large body of literature that demonstrates that traffick-
ing through the endolysosomal system is an evolutionarily 
conserved mechanism to regulate Notch activity (Baron, 2012; 
Kandachar and Roegiers, 2012). Notch is constantly endocy-
tosed (McGill et al., 2009), and the signaling outcome arising 
from this internalized pool of Notch is carefully controlled by 
several factors. On the one hand, the protein Numb is a con-
served inhibitor of the pathway that acts at this level (Cotton et 
al., 2013; Couturier et al., 2013, 2014; Reichardt and Knoblich, 
2013). This factor interacts with components of the AP-2 com-
plex and prevents endosome-to-plasma membrane recycling of 
Notch; in addition, Numb also promotes the lysosomal degra-
dation of the receptor (McGill et al., 2009). In contrast, Deltex, 
an E3 ligase, has been shown to promote Notch signaling in a 
ligand-independent manner (Sakata et al., 2004; Wilkin et al., 
2008; Hori et al., 2011, 2012; Troost et al., 2012). Acting in 
concert with the homotypic fusion and protein sorting com-
plex and Rab7, Deltex promotes the trafficking of Notch to late 
endosomes. Interestingly, in this pathway, the localization of 
Notch is restricted to the limiting membrane of late endosomes, 
preventing the entry of the receptors into the multivesicular 
body. From this location, a ligand-independent cleavage event 
is thought to occur, resulting in pathway activation. Countering 
Deltex are HECT domain–containing ligases, such as Itch in 
mammals and Suppressor of Deltex in Drosophila (Wilkin et 
al., 2004; Chastagner et al., 2006), which promote the entry of 
Notch into the multivesicular body, resulting in its degradation.
Another intriguing observation made here is that the 
CCC complex, previously shown to regulate retromer/WASH- 
dependent endosomal trafficking, can have distinct configura-
tions dictated by the incorporation of specific COM MD protein 
complexes. We show that COM MD5 and COM MD10 interact 
preferentially with COM MD9 and depend on this protein for 
their interaction with the CCC complex. The data further suggest 
that COM MD9–COM MD5 complexes are particularly important 
for Notch trafficking and can bind with the cytoplasmic tail of 
Notch2 in vitro. This raises the possibility that distinct CCC sub-
complexes are generated to regulate specific cargoes and that per-
haps COM MD proteins assist in cargo selection in this pathway.
In addition, it is reasonable to speculate that COM MD9 
is likely to regulate many more receptors besides Notch. The 
identification of additional COM MD9-regulated cargoes will 
require proteome-wide analyses, such as those recently used 
to uncover retromer-regulated cargoes (Steinberg et al., 2013). 
This information would likely provide key insights that will be 
important to understand the developmental phenotypes result-
ing from Commd9 deficiency. Our analysis identified several 
vascular and cardiac alterations, but the phenotype could not be 
ascribed entirely to the deficiency of a singular Notch receptor. 
For example, Notch1 deficiency has more prominent effects on 
arterial fate decisions (Lawson et al., 2001; Fischer et al., 2004; 
Gridley, 2010) rather than the phenotype in the venous vascu-
lature observed here. Isolated Notch2 deficiency is embryoni-
cally lethal at about the same stage as Commd9 deficiency and 
is also associated with cardiac hypoplasia (Hamada et al., 1999; 
McCright et al., 2006), but only a small percentage of these 
mutant embryos exhibit neural and abdominal hemorrhages 
(Wang et al., 2012), as we routinely saw in Commd9-deficient 
embryos. Although Notch3 deficiency is viable, combined 
Notch2/Notch3 recapitulated more aspects of the phenotype 
of Commd9-deficient embryos. For example, concurrent defi-
ciency of these factors results in frequent obstructions of the 
dorsal aortas and also leads to frequent cerebral and abdominal 
hemorrhages, as we saw here (Wang et al., 2012). However, 
Figure 6. COM MD9 interacts and colocalizes with COM MD5. (A) Colo-
calization of COM MD9 and COM MD5 was evaluated in HeLa cells after 
CRI SPR-mediated deletion and rescue of COM MD9 expression (Fig. 2 D; 
HA tagged, clone 3). Immunofluorescence staining for COM MD9 (HA) 
and COM MD5 was followed by confocal microscopy imaging. Bar, 10 
µm. (B) In vitro binding between the indicated recombinant COM MD pro-
teins. The indicated combinations of COM MD proteins were expressed in 
E. coli as described in the Materials and methods section. After lysis, one 
of the proteins (fused to the GST or MBP tag) was precipitated, and the 
presence of the partner COM MD protein was assessed by Coomassie blue 
staining. Molecular mass markers (in kD) are shown.
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this phenotype in Notch2/Notch3-deficient embryos is largely 
driven by smooth muscle–dependent signals; in contrast, 
smooth muscle deletion of Commd9 did not recapitulate the 
embryonic lethality. Altogether, our interpretation is that the 
developmental phenotypes in Commd9-deficient embryos are 
likely the result of alterations in additional receptors. In this 
regard, the fact that COM MD9 is frequently included in the 
genomic interval deleted in WAGR syndrome highlights the 
biomedical importance of understanding these events. Patients 
with WAGR are affected by a high risk for Wilms’ tumors and 
have several congenital anomalies, including aniridia, geni-
tourinary abnormalities, intellectual disability, and frequent 
cardiac anomalies (Fischbach et al., 2005). We examined our 
heterozygote mice for any of these phenotypes and found no 
overt pathology, but cooperation between COM MD9 and other 
genes may be relevant to the human condition.
In summary, this study identifies that COM MD9, acting 
in concert with the CCC and retromer complexes, regulates the 
endosomal sorting of Notch and its delivery to the cell surface. 
This constitutes a regulatory step in the Notch pathway that has 
not been previously appreciated. Future studies are likely to un-
cover that members of the COM MD protein family play simi-
larly critical roles in the endosomal sorting of other important 
cell-surface receptors.
Materials and methods
Mouse strains
Mice were housed in conventional facilities and fed a standard diet. 
All animal procedures were approved by the institutional animal care 
and use committee. Gene-trapped Commd9 mice were derived by the 
Transgenic Animal Model Core facility at The University of Michi-
gan through blastocyst injection using an embryonic stem cell line 
(AQ0362) obtained from the Sanger Institute Gene Trap Resource 
(stock number 017754-UCD). The nature of the genomic targeting 
was confirmed by Southern blotting. Animals were genotyped by PCR 
using the following primers: 5′-TGC ATGCC ATAGA GCCCA CTTGT-
3′, 5′-TAG CAGCA GCCCC TCCAT CACACT-3′, and 5′-GGG CTACC 
GGCTA AAACT TGAGAC-3′. This amplification yields a 530-bp prod-
uct for the wild-type allele and a 771-bp product for the targeted allele. 
Mice with the conditional Commd9 allele (Commd9F/F), which contains 
LoxP sites flanking exon 3 of the Commd9 gene, were generated by the 
Transgenic and Knockout Core at Mayo Clinic through blastocyst in-
jection using an embryonic stem cell line (EPD0136_6_D10) obtained 
from The Knockout Mouse Project. Animals were genotyped by PCR 
using the following primers: 5′-AAG GTGGA AACAC ATAGC CAG-3′ 
and 5′-TTA CTAGG CAACC CTGCA TTG-3′. This amplification yields 
a 297-bp product for the wild-type allele and a 489-bp product for the 
targeted allele. Sox2-Cre transgenic mice are available from the Jack-
son Laboratory. This mouse strain contains a transgenic construct con-
sisting of the promoter of the Sox2 gene, which drives expression of 
Cre in the epiblast as early as E6.5 (Hayashi et al., 2002). The Nkx2.5-
Cre mouse strain was provided by E. Olson (University of Texas South-
western, Dallas, TX). This mouse contains a transgene consisting of a 
2.5-kb fragment encompassing the promoter and cardiac enhancer of 
the Nkx2-5 gene, which drives expression of Cre in the myocardium 
(McFadden et al., 2005). The Tie2-Cre mouse was provided by M. Yan-
agisawa (University of Texas Southwestern, Dallas, TX). This mouse 
contains a transgene consisting of the endothelial-specific promoter/
enhancer of the Tek (Tie2) gene, which drives expression of Cre in en-
dothelial cells (Kisanuki et al., 2001). The Sm22-Cre mouse was pro-
vided by H.  Yanagisawa (University of Texas Southwestern, Dallas, 
TX). This mouse contains a transgene consisting of a smooth muscle–
Figure 7. COM MD9 and its partner COM MD5 reg-
ulate Notch2. (A and B) The effects of COM MD9 
deficiency on COM MD5 and COM MD10 interac-
tions with the CCC complex were evaluated in two 
CRI SPR clones. Endogenous input levels for several 
COM MD proteins were not substantially affected (A). 
In contrast, COM MD5 and COM MD10 interactions 
with the CCC complex subunit CCDC22 were lost 
in COM MD9-deficient cells. COM MD4, COM MD6, 
and COM MD8 were unaffected (B). Molecular mass 
markers (in kD) are shown. (C) In HEK 293T cells, 
each individual COM MD gene was silenced using 
siRNA transfection. Deficiency of either COM MD5 
or COM MD9 led to reduced Notch2 expression. 
All other siRNA treatments did not affect this recep-
tor. Molecular mass markers (in kD) are shown. (D) 
In vitro binding between an immunopurified Notch2 
C-terminal polypeptide and recombinant COM MD 
complexes was evaluated by coprecipitation. Only 
COM MD5-containing complexes bound to Notch2. 
Molecular mass markers (in kD) are shown.
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specific promoter from the Tagln (Sm22) gene and the coding sequence 
of Cre recombinase (Holtwick et al., 2002).
Cell culture
HEK293T, U2OS, and HeLa cells were obtained from the American 
Type Culture Collection. HeLa shRNA stable cells for CCC and retromer 
components were generated by lentiviral infection of HeLa cells. Vi-
ruses were produced using the shRNA expression vector pLKO.TRC, in-
cluding specific targeting sequences that have been previously reported 
(Phillips-Krawczak et al., 2015). Mouse Commd1-deficient fibroblasts 
were generated by harvesting Commd1f/f embryos at E13.5 and deriving 
primary MEFs cultures from the embryonic soma. These cultures were 
immortalized using lentiviral vectors expressing E1A and Ras. Immor-
talized MEFs were then transiently infected with an adenoviral vector 
expressing Cre, resulting in Commd1 deletion, as described previously 
(Vonk et al., 2011). Dermal fibroblasts from patients with the CCDC22 
p.T17A mutation (Voineagu et al., 2012) were obtained and immor-
talized through stable expression of telomerase; these cells have been 
reported previously (Starokadomskyy et al., 2013). MEFs from gene trap 
and floxed Commd9 mouse embryos were harvested and immortalized 
as described here for Commd1-deficient fibroblasts (Vonk et al., 2011). 
OP9-Jagged1 cells were generated by transduction of the murine bone 
marrow stromal cell line OP9 with a retroviral vector expressing human 
Jagged1, as previously reported (Dontje et al., 2006). All cell lines were 
maintained in high-glucose DMEM containing 10% FBS. Treatment 
with Bafilomycin A1 (Tocris) consisted of adding this reagent to the 
growth media (100 nM) for 24 h. Stimulation with plate-bound Jagged1 
(R&D Systems) consisted of first applying the ligand to empty growth 
plates for 24 h (0.5 µg per well of a six-well plate). Thereafter, the plates 
were rinsed, and cells were seeded onto these plates; 48 h later, RNA 
was extracted from these cells for analysis. Stimulation with OP9 cells 
expressing Jagged1 consisted of first seeding the stimulating cells onto 
plates and allowing them to reach confluency. At that point, cells were 
rinsed and fixed with sterilized 4% PFA at room temperature for 15 min. 
After thoroughly rinsing the fixative, target cells were seeded onto these 
coated plates; 48 h later, RNA was extracted from these cells for analysis.
Plasmids, RNAi, and CRI SPR/Cas9
The pEBB vector is a derivative of pEF-BOS (Mizushima and Nagata, 
1990) and contains an EF-1α promoter for mammalian protein expres-
sion. A series of derivatives of the pEBB vector (pEBB-HA, pEBB-
2xHA-TB, pEBB-HA-COM MD9, and pEBB-2xHA-COM MD9-TB) 
were generated for these studies through conventional cloning tech-
niques and have been previously described (Starokadomskyy et al., 
2013). pEBB-AcGFP1-Rab5c and pEBB-AcGFP1-Rab11b are deriv-
atives of pEBB containing the coding sequence for the fluorescent pro-
tein AcGFP1 and the ORFs for Rab5c and Rab11b, respectively. These 
were cloned into the BamHI and NotI sites of the pEBB-AcGFP1 
vector (Phillips-Krawczak et al., 2015). A series of bacterial expression 
vectors were generated through conventional cloning techniques and 
include pET30a-His-COM MD1 (expressing His-tagged COM MD1), 
pGEX-4T1-GST-COM MD6 (expressing GST-tagged COM MD6), 
pRSF-His-COM MD9 (expressing His-tagged COM MD9), and 
p15Cool2-MBP-COM MD5 (expressing MBP-tagged COM MD5. 
The Notch reporter plasmid Notch-CBF1 contains multimerized RBPj 
binding sites and was shared by L.  Lum with permission from the 
original developers of the construct (Baladrón et al., 2005). The pcD-
NA-human Notch2FL vector, which expresses full-length untagged 
Notch2, was provided by Artavanis-Tsakonas Lab (Zagouras et al., 
1995). pEBB-2xHA-human Notch2 C terminus (intracellular domain) 
was PCR amplified from pcDNA-human Notch2FL and cloned into 
BamHI–NotI sites of pEBB-2xHA vector. For lentiviral expression 
of HA-tagged COM MD9, we used the lentiviral FG9 vector (Wright 
and Duckett, 2009). After cloning into the XbaI sites, we generated 
the FG9-PuroR-HA-COM MD9 vector. A “CRI SPR-resistant” version 
of COM MD9 was introduced into a lentiviral vector (FG9-HygroR-
2xHA-Crispr resistant COM MD9) after introducing silent mutations 
in COM MD9 (site-directed mutagenesis kit; Agilent Technologies) 
using the following primer: 5′-GCA AGATG GCTGC CCTAA CGGCA 
GAGCA TTTTG CAGCAC-3′ (mutated nucleotides are underlined). 
The siRNA duplexes used in this study are described in Table S2. 
Stable shRNA-mediated silencing was performed using the lentiviral 
vector pLKO.TRC. CRI SPR-mediated inactivation of COM MD9 was 
performed through stable expression of a targeting guide RNA (gRNA) 
and Cas9, using the pLEN TI-CRI SPR vector (Mali et al., 2013; Shalem 
et al., 2014). Deleted clones were isolated through limiting dilution 
and screened for COM MD9 expression by immunoblot. Genomic 
DNA was isolated from individual clones, and genomic regions around 
the targeted area were amplified using the following primers: forward 
(5′-TCT CGGGG TTTAG TCATC CAGCC-3′) and reverse (5′-AGC 
AGGAG GTTGT ATTGC GCCT-3′). These PCR products were cloned 
into PCR 2.1 TA vector (Life Technologies), and individual clones 
were sequenced. Nested PCR to obtain a shorter 283-bp product was 
performed using primers as forward (5′-ACC ACAAC CGAAA CGCCT 
TCCC-3′) and reverse (5′-AGC AGCAG AGTTG TGGCT CCAA-3′). 
The resulting amplified products were resolved in 3% Nu-Sieve aga-
rose gels. All targeting sequences used in the various approaches men-
tioned here are noted in Table S2.
Transfection and viral transduction
The following transfection reagents were used: calcium phosphate 
(for plasmids and siRNA in HEK293T cells), Fugene (Roche, for 
plasmids in U2OS cells), and RNAiMAX (for siRNA in HeLa cells; 
Life Technologies). Lentiviral production was achieved through 
transient transfection of HEK293T cells with packaging and ex-
pression lentiviral vectors. Culture supernatants containing viral 
particles were harvested 48  h later, and after filtration through a 
0.45-µm filter, this supernatant was applied to the intended cell tar-
get. The lentiviral expression vectors used here included puromycin 
or hygromycin resistance as selection markers, which were used to 
select stably transduced cells as described previously in more de-
tail (Maine et al., 2007).
RNA extraction and RT-PCR
RNA extraction from cultured cells was performed using the Trizol 
method (Life Technologies) according to standard protocols. RNA 
extraction from isolated embryo hearts was performed using RNeasy 
columns (QIA GEN). Quantitative RT-PCR was performed using the 
Sybr green method, and relative quantitation was performed accord-
ing to the 2(−ΔΔCt) algorithm as previously reported (Maine et al., 2007; 
Starokadomskyy et al., 2013). The primers used for each of the gene 
targets examined here are noted in Table S3. All experiments involved 
biological and technical replicates (n = 3) and were performed at least 
three independent times.
Protein extraction, immunoblotting, immunoprecipitation, and 
luciferase assays
Cell lysate preparation, immunoprecipitation, and immunoblotting 
were performed as previously described (Maine et al., 2007). Immuno-
blotting and immunoprecipitation experiments were performed using a 
Triton X-100 lysis buffer (25 mM Hepes, 100 mM NaCl, 10 mM DTT, 
1 mM EDTA, 10% glycerol, and 1% Triton X-100). All Western blots 
presented in this paper are representative of at least three independent 
iterations for each experiment. Luciferase assays were performed by 
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transfecting the luciferase reporter plasmid vector (Notch-CBF1) into 
U2OS cells. After 24 h, the cells were lysed, and 10 µl whole-cell ly-
sate was loaded onto a 96-well luminometer plate. Luciferase substrate 
(Promega) was injected, and light emission was measured using a lumi-
nometer plate reader (EnVision; PerkinElmer), as previously reported 
(Burstein et al., 2005).
In vitro binding assay
Bacterial expressing plasmids were individually transformed or 
cotransformed into to E. coli BL21 (DE3) cells (Invitrogen). All cells 
were grown in LB at 37°C with appropriate antibiotics until OD600 
reached 0.6, and they were then shifted to 25°C for at least 30 min. 
Proteins were expressed at 25°C for 12–16  h by induction with 
0.4 mM IPTG. Cells were resuspended in PBS buffer supplied with β- 
mercaptoethanol and protease inhibitors and lysed by sonication. The 
lysate was cleared by centrifugation at 12,000 rpm at 4°C for 30 min. 
For MBP-COM MD5, MBP-COM MD5/His-COM MD1, and MBP-
COM MD5/His-COM MD9, clarified supernatant was purified using 
Amylose resin (NEB). For His-COM MD1/GST-COM MD6, superna-
tant was purified using glutathione agarose affinity resin (Molecular 
Probe). After incubation at 4°C for 30 min, the resin was washed four 
times with PBS buffer. Proteins bound to the resin were eluted with 
maltose and glutathione.
pEBB-2xHA-Notch2 C terminus was expressed in HEK293T 
cells, and Notch2-C was immunoprecipitated with HA-affinity beads 
(Roche). After extensive washing, the protein was eluted from the 
column with excess HA peptide (Anaspec). GST and His-COM MD1/
GST-COM MD6 elution were rebound to glutathione resin. MBP, 
MBP-COM MD5, and MBP-COM MD5/His-COM MD9 elution were 
rebound to Amylose resin. The beads bound to these recombinant 
COM MD complexes were blocked with 5% BSA for 1 h at 4°C. Eluted 
Notch2-C was then mixed for 1  h at 4°C with COM MD complexes 
immobilized onto beads. After extensive washing of these beads, the 
material was resolved by SDS-PAGE and immunoblotted with HA an-
tibody to detect 2xHA-Notch2 C terminus. The SDS-PAGE gels were 
stained with Coomassie blue.
Antibodies
All other antibodies used in this study are listed in Table S4. COM MD 
protein antibodies were generated by immunizing rats (COM MD1, 
COM MD2, and COM MD3), rabbits (COM MD4, COM MD5, 
COM MD9, and COM MD10), and guinea pigs (COM MD8) with re-
combinant GST fusion proteins encoding the N-terminal regions 
(proximal to the COMM domains) of the respective COM MD pro-
teins (Cocalico Biologicals). The obtained sera were thereafter affin-
ity purified using a His6-tagged version of the respective immunogen 
(AminoLink Coupling Resin and Immobilization kit; Thermo Fisher 
Scientific). The antibodies were characterized by testing their ability 
to recognize FLAG-tagged protein expressed in HEK293 cells with-
out cross reactivity to other COM MDs and to recognize endogenous 
protein (using siRNA as an additional control). Previously made cus-
tom antibodies to COM MD1, COM MD6, and COM MD9 have been 
reported (Starokadomskyy et al., 2013).
Immunofluorescence staining
Cell staining was performed as previously reported (Phillips-Krawczak 
et al., 2015). In brief, cells were seeded in chambered slides and fixed 
in 4% PFA, permeabilized, and thereafter stained using the specific an-
tibodies indicated in each experiment. The fluorochromes used in the 
secondary antibodies used for staining were Alexa Fluor 488 and Alexa 
Fluor 555 (Invitrogen). Images were obtained at room temperature 
using any of the following confocal microscopes: LSM 510 (63×/1.4 
oil immersion objective lens; Carl Zeiss), LSM 710 (63×/1.4 oil im-
mersion objective lens; Carl Zeiss), or A1R (60×/1.4 oil immersion 
objective lens; Nikon). Images were acquired using LSM 510 (Carl 
Zeiss), ZEN software (Carl Zeiss), and NIS-Elements AR (Nikon) 
software, respectively. Obtained images were analyzed using the LSM 
image browser, ZEN software, or Fuji ImageJ.
Biotinylation of plasma membrane proteins
Cell-surface biotinylation was performed as previously described (Phil-
lips-Krawczak et al., 2015). In brief, NHS SS-biotin (Pierce) dissolved 
in biotinylation buffer (10  mM triethanolamine, 150  mM NaCl, and 
2 mM CaCl2, pH 8.0) was used for surface labeling at 4°C for 30 min. 
The biotinylated antigens were precipitated using NeutrAvidin agarose 
resin (Pierce). Precipitated protein-containing beads were then resus-
pended in LDS sample buffer (Life Technologies) with 250 mM DTT. 
Proteins were then subjected to SDS-PAGE, and membranes were 
probed for Notch2 and N-cadherin.
Tandem affinity purification
This was performed by sequential purification through HA binding resin 
(Roche) and Streptavidin agarose (Pierce). In brief, 10 plates of seeded 
HEK 293 cells (15 cm each) were transfected with pEBB-2xHA-TB or 
pEBB-2xHA-COM MD9-TB. Two days later, a cell lysate was prepared 
in Triton X-100 lysis buffer as described in the Protein extraction section. 
The lysate was incubated with HA binding resin at 4°C for 2 h. At that 
point, the bait was eluted three times using excess HA peptide (1 mg/
ml in 20 mM Tris-HCl, pH 7.4, 100 mM NaCl, and 0.1 mM EDTA). 
This pooled eluate was applied to a streptavidin agarose beads for 2 h 
at 4°C. Subsequently, the beads were washed extensively, and proteins 
were resolved by SDS-PAGE. After Coomassie stain, bands were excised 
and submitted to the Proteomics core at University of Texas Southwest-
ern for trypsin digestion and peptide identification through LC/MS-MS 
analysis protein identification. A repeat iteration of this experiment was 
performed nearly identically except that most of the precipitated material 
bound to beads was submitted to the Taplin Mass Spectrometry Facility. 
A small aliquot of the precipitated material was resolved by SDS-PAGE 
and stained using silver nitrate (Invitrogen).
Embryological analysis
Timed pregnancies were setup to allow embryo harvesting at specified 
embryologic stages. Yolk sacs were used as a source of DNA for geno-
typing. For conventional histologic analysis (HE sections), the embryos 
were rinsed in PBS and then fixed in 4% PFA in 1× PBS overnight at 4°C 
with gentle rocking. Thereafter, embryos were dehydrated and stored in 
75% ethanol at −20°C. For paraffin embedding, embryos were washed 
twice in 100% ethanol and xylene for 1 h each, followed by a series 
of rinses in 100% Paraplast Plus tissue embedding medium (McCor-
mick) at 60°C. Subsequently, these embryos were paraffin embedded, 
sectioned, and stained according to standard techniques. For immuno-
fluorescence, fixed embryos were rehydrated in stepwise fashion to 1× 
PBS and rinsed in 30% sucrose overnight at 4°C. The embryos were 
then embedded in Tissue-Tek O.C.T. compound and sectioned at 10 µm 
using a cryostat. Antigen retrieval was performed using Buffer A solu-
tion (Electron Microscopy Sciences). The slides were washed in 1× PBS 
and blocked for 1 h in Cas-Block (Invitrogen) before primary antibodies 
were added for overnight incubation at 4°C. Signals were detected the 
following day using fluorescently labeled secondary antibodies. The 
slides were mounted with ProLong Gold Antifade (Invitrogen). Whole-
mount in situ hybridization was performed as previously reported (Xu 
et al., 2009). In brief, the fixed embryos were treated with proteinase K, 
fixed in a 0.25% glutaraldehyde and 4% PFA solution, and prehybridized 
at 60°C for 1 h. The samples were transferred into hybridization mix, 
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containing a digoxigenin-labeled probe. Further in situ hybridization 
steps were performed with a series of washing buffer, and then develop-
ment of color reaction was done using BM purple (Roche). RNA probes 
were generated from the following clones: Apj (BC039224; Open Bio-
systems) and Cx40 (BC053054; Open Biosystems). Whole-embryo 
images were obtained with a Stemi 2000-C stereomicroscope (Carl 
Zeiss) at magnification of 12.5, using a Canon PowerShot G10 camera 
and AxioVision Rel 4.8 software (Carl Zeiss). In situ staining images 
were obtained with a NeoLumar Stereomicroscope (Carl Zeiss) with 
50×, 75×, or 80× magnification and a DP-70 camera (Olympus) with 
DP manager software (Olympus). Images of histologic sections were 
obtained with a DM2000 microscope (Leica) with 4×/0.70, 10×/0.70, 
20×/0.70, or 40×/0.75 objective lenses and a Microfire CCD camera 
(Optronics) with PictureFrame 2.0 software (Optronics).
Online supplemental material
Fig. S1 shows additional information regarding the CRI SPR-targeting 
strategy used to generated COM MD9-deleted HeLa cell clones (Cr-
COM MD9). In addition, characterization of the resulting indels is 
shown. Fig. S2 shows additional details of the intracellular localization 
of Notch2 in COM MD9-deficient HeLa cells. Fig. S3 displays 
the effects of CCC or retromer deficiency on Notch2 intracellular 
localization. Fig. S4 contains details regarding the generation of the 
two knockout mouse models used here (gene trap and conditional 
deletion of Commd9). Additional morphologic data concerning the 
phenotype of Commd9-deficient embryos are also shown. Fig. S5 shows 
comparative coimmunoprecipitation of selected COM MD proteins and 
their associated complexes. Table S1 includes all the hits identified 
in the tandem affinity purification screen for COM MD9-associated 
proteins. Table S2 provides sequences for siRNA, shRNA, and CRI 
SPR reagents used in this paper. Table S3 provides sequences for 
primers used for quantitative RT-PCR (qRT-PCR). Table S4 includes 
detailed information for all antibodies used here, including custom-
made antibodies against all COM MD proteins which were generated 
for this study. Online supplemental material is available at http ://www 
.jcb .org /cgi /content /full /jcb .201505108 /DC1.
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